This is the fi fth revision of Preventing Lead Poisoning in Young Children by the Centers for Disease Control and Prevention (CDC).As with the previous statements, the recommendations presented here are based on scientific evidence and practical considerations. This revision accompanies a companion document,A Review of Evidence ofAdverse Health EffectsAssociated with Blood Lead Levels <10 µg/dL in Children, developed byAdvisory Committee on Lead Poisoning Prevention which reviews the scientific evidence for adverse effects in children at blood lead levels below 10 µg/dL. The data demonstrating that no “safe” threshold for blood lead levels (BLLs) in young children has been identifi ed highlights the importance of preventing childhood exposures to lead. It confi rms the need for a systematic and society wide effort to control or eliminate lead hazards in children’s environments before they are exposed. This emphasis on primary prevention, although not entirely new, is highlighted here and is clearly the foremost action supported by the data presented inA Review of Evidence ofAdverse Health EffectsAssociated with Blood Lead Levels <10 µg/dL in Children. Although there is evidence of adverse health effects in children with blood lead levels below 10 µg/dL, CDC has not changed its level of concern, which remains at levels >10 µg/dL. We believe it critical to focus available resources where the potential adverse effects remain the greatest. If no threshold level exists for adverse health effects, setting a new BLL of concern somewhere below 10 µg/dL would be based on an arbitrary decision. In addition, the feasibility and effectiveness of individual interventions to further reduce BLLs below 10 µg/dL has not been demonstrated. CDC is conducting several activities to focus efforts on preventing lead exposures to children. First, beginning in 2003, CDC required state and local health departments receiving funding for lead poisoning prevention activities to develop and implement strategic childhood lead poisoning elimination plans. Second, CDC and its federal partners, the Department of Housing and Urban Development and the Environmental ProtectionAgency, launched new initiatives to control lead-based paint hazards in the highest risk housing, addressing where successive cases of lead poisoning have been identified. Third, CDC and other federal agencies are developing a systematic and coordinated response to identify and eliminate nonpaint sources of exposure (e.g., lead jewelry, food and traditional medicines, and cosmetics). CDC continues to monitor progress toward the Healthy People 2010 objective of eliminating elevated BLLs in children at the national level through the National Health and Nutritional Examination Survey and at the state and local levels through the blood lead surveillance system. These complementary data provide essential information for the rational distribution of resources to communities with the highest risk for lead exposure. I wish to thank both current and former members of theAdvisory Committee on Childhood Lead Poisoning Prevention and consultants who developed the documents in this statement and acknowledge their contribution to the health of the nation’s children. The Committee considered a number of controversial issues, examined the existing data and reviewed the report of the work group. This 2005 statement represents agreement of 12 of the 13Advisory Committee members serving on the committee as of October 19-20, 2004.
December 12th, 2017